{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:54:55Z","timestamp":1791550495996,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jiac.2026.103089","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:37:55Z","timestamp":1790836675000},"page":"103089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive performance of single-trough Bayesian estimation for vancomycin across body mass index categories using Practical Antimicrobial Therapeutic Drug Monitoring (PAT) version 4.0"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9714-1222","authenticated-orcid":false,"given":"Kaori","family":"Arai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiseki","family":"Usami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.103089_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jiac.2026.103089_bib2","unstructured":"Japanese Society of Chemotherapy, Japanese Society of Therapeutic Drug Monitoring. Antimicrobial therapeutic drug monitoring clinical practice guidelines 2022. Tokyo: Japanese Society of Chemotherapy; 2022."},{"key":"10.1016\/j.jiac.2026.103089_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1345\/aph.1P634","article-title":"Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software","volume":"45","author":"Nunn","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jiac.2026.103089_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jiac.2019.04.017","article-title":"Evaluation for optimal dosing of vancomycin in patients with different physical types","volume":"25","author":"Hashimoto","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103089_bib5","first-page":"11","article-title":"Investigation of vancomycin AUC deviations in underweight patients","volume":"107","author":"Kuroda","year":"2024","journal-title":"J Hokkaido Soc Hosp Pharm"},{"key":"10.1016\/j.jiac.2026.103089_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11095-021-03030-y","article-title":"Performance of area under the concentration-time curve estimations of vancomycin with limited sampling by a newly developed web application","volume":"38","author":"Oda","year":"2021","journal-title":"Pharm Res"},{"key":"10.1016\/j.jiac.2026.103089_bib7","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jiac.2024.05.014","article-title":"Validation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web application","volume":"30","author":"Oda","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103089_bib8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/phar.4613","article-title":"Impacts of age and BMI on vancomycin model choice in a Bayesian software: lessons from a very large multi-site retrospective study","volume":"44","author":"Hughes","year":"2024","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2026.103089_bib9","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s11095-024-03781-4","article-title":"Identification of patients who require two-point blood sampling for the peak and trough values rather than one-point blood sampling for the trough value for the evaluation of AUC of vancomycin using Bayesian estimation","volume":"41","author":"Suzuki","year":"2024","journal-title":"Pharm Res"},{"key":"10.1016\/j.jiac.2026.103089_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2025.102821","article-title":"Evaluating the necessity of two-point sampling for vancomycin area under the curve in follow-up therapeutic drug monitoring","volume":"31","author":"Suzuki","year":"2025","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103089_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2014.05.016","article-title":"Innovative approaches to optimizing the delivery of vancomycin in individual patients","volume":"77","author":"Pai","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jiac.2026.103089_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-1-62703-050-2_16","article-title":"Non-compartmental analysis","volume":"929","author":"Gabrielsson","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jiac.2026.103089_bib13","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1248\/bpb.b25-00562","article-title":"Comparison of trough-only and peak-trough concentration data for the calculation of vancomycin area under the concentration-time curve on day 1 or day 2","volume":"48","author":"Endo","year":"2025","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jiac.2026.103089_bib14","unstructured":"Japan Society for the Study of Obesity. Guidelines for the management of obesity disease 2022. Tokyo: Life Science Publishing Company; 2022."},{"key":"10.1016\/j.jiac.2026.103089_bib15","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jiac.2026.103089_bib16","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jiac.2026.103089_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.jiac.2026.103089_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.07.005","article-title":"Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients","volume":"27","author":"Cunio","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2026.103089_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/FTD.0000000000000250","article-title":"Evaluation of vancomycin prediction methods based on estimated creatinine clearance or trough levels","volume":"38","author":"Haeseker","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jiac.2026.103089_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cardfail.2016.06.423","article-title":"Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial","volume":"22","author":"Brisco","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.jiac.2026.103089_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003088-198611040-00001","article-title":"Clinical pharmacokinetics of vancomycin","volume":"11","author":"Matzke","year":"1986","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jiac.2026.103089_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2215\/CJN.02870707","article-title":"Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C","volume":"3","author":"Baxmann","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jiac.2026.103089_bib23","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/jcsm.12969","article-title":"Muscle mass and estimates of renal function: a longitudinal cohort study","volume":"13","author":"Groothof","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jiac.2026.103089_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072415","article-title":"Frequency and characteristics of overestimated renal function in Japanese patients with chronic liver disease and its relation to sarcopenia","volume":"13","author":"Yoshida","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jiac.2026.103089_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00007691-199410000-00013","article-title":"Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight","volume":"16","author":"Ducharme","year":"1994","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jiac.2026.103089_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00007691-199804000-00003","article-title":"Population pharmacokinetics of vancomycin in Japanese adult patients","volume":"20","author":"Yasuhara","year":"1998","journal-title":"Ther Drug Monit"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2600187X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2600187X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:27:15Z","timestamp":1791548835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2600187X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":26,"alternative-id":["S1341321X2600187X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103089","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive performance of single-trough Bayesian estimation for vancomycin across body mass index categories using Practical Antimicrobial Therapeutic Drug Monitoring (PAT) version 4.0","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103089"}}